Blackstone Group »

Jazz Pharmaceuticals shares owned by Blackstone Group

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Blackstone Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.0M 4.4k 240.97

More positions owned by Blackstone Group

Cheniere Energy Partners Com Unit (CQP)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Digital Realty Trust (DLR)
Corebridge Finl (CRBG)
Legence Corp Cl A (LGN)
FirstEnergy (FE)
Williams Companies (WMB)
Targa Res Corp (TRGP)
Enterprise Products Partners (EPD)
Kinder Morgan (KMI)
Enbridge (ENB)
MPLX Com Unit Rep Ltd (MPLX)
Energy Transfer Com Ut Ltd Ptn (ET)
Kinetik Holdings Com New Cl A (KNTK)

View all positions for Blackstone Group

Top funds holding Jazz Pharmaceuticals

BlackRock
FMR
Vanguard Portfolio Management
Vanguard Capital Management
Capital World Investors
LSV Asset Management
Franklin Resources
State Street Corporation
Dimensional Fund Advisors
Hanna Zanoni
Bank of New York Mellon
AQR Capital Management
Geode Capital Management
Ameriprise Financial
Jpmorgan Chase & Co

View all funds holding Jazz Pharmaceuticals